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Bound Water Structure and Polymorphic Amino
Acids Act Together to Allow the Binding of
Different Peptides to MHC Class I HLA-B53
Kathrine J. Smith,*§ Scott W. Reid,² sampling of peptide epitopes necessary for cellular im-
mune function. For a full understanding of the range andKarl Harlos,²³ Andrew J. McMichael,*
limits of this system in the human population, we stillDavid I. Stuart,²³ John I. Bell,*
require data on the structural elements that confer cer-and E. Yvonne Jones²³
tain common anchor specificities and the mechanisms*Molecular Immunology Group
that delimit the degeneracy of peptide binding.Nuffield Department of Clinical Medicine
There are three major distinct loci (A, B, and C) ex-Institute of Molecular Medicine
pressing MHC class I heavy chain in humans. To date,John Radcliffe Hospital
HLA-B27 is the only non-A locus human allele for whichOxford, OX3 9DU
a crystallographic structural analysis has been under-United Kingdom
taken and this has been achieved only with a heteroge-²Laboratory of Molecular Biophysics
neous population of peptides bound (Madden et al.,³Oxford Centre for Molecular Sciences
1992). We report here the crystal structure of a humanDepartment of Biochemistry
class I B allele, HLA-B53 (HLA-B*5301), complexed withThe Rex Richards Building
two different nonameric peptide epitopes. HLA-B53, aUniversity of Oxford
common allele in West Africa (Allsopp et al., 1991), hasSouth Parks Road
been shown to be associated with resistance to severeOxford OX1 3QU
forms of malaria in the Gambia (Hill et al., 1991). AminoUnited Kingdom
acid sequencing of pools of peptides eluted from this
protein (Hill et al., 1992) reveal a peptide-binding motif
with a strong preference for Pro at the second position
Summary (P2). This preference is common to a large number of
MHC class I alleles, including the HLA-B alleles HLA-
The structure of thehuman MHC class I molecule HLA- B35, HLA-B51, HLA-B7 (Rammensee and Friede, 1995),
B53 complexed to two nonameric peptide epitopes subtypes of HLA-B22 (Barber et al., 1995), and the mu-
(from the malaria parasite P. falciparum and the HIV2 rine allele H-2Ld (Corr et al., 1992). Pro is an interesting
gag protein) has been determined by X-ray crystallog- anchor residue due to its small size and lack of hydro-
raphy at 2.3 AÊ resolution. The structures reveal the gen-bonding potential. Specific complexes with B53
architecture of a Pro-specific B pocket common to provide the opportunity to characterize the nature of the
many HLA-B alleles. Relative to other alleles, the B53 Pro pocket. Crystal structures have been determined,
peptide-binding groove is widened by a significant (up each to 2.3 AÊ resolution, of B53 complexed with two
to 1.25 AÊ ) shift in the position of the a1 helix. Within peptides containing Pro at the P2 position. First, the
this groove, bound water molecules, acting in concert peptide ls6 (KPIVQYDNF) from the malaria parasite P.
with the side chains of polymorphic residues, provide falciparum, an epitope that has been shown to be recog-
the functional malleability of the MHC, which enables nized by B53-restricted cytotoxic T lymphocytes (CTLs)
the highaffinity/low specificity binding of multiple pep- (Hill et al., 1992). Second, the epitope gag (TPYDINQML)
tide epitopes. from HIV2, which is recognized by B53-restricted CTLs
from HIV2-infected Gambians (Gotch et al., 1993). The
study of HLA-B53 also establishes how aromatic resi-Introduction
dues at the C terminus of the peptide are accommo-
dated; previous single-peptide structures have all beenSpecific recognition by T cell receptors (TCRs) of pep-
for peptides with aliphatic or positively charged aminotide antigen bound to major histocompatibility complex
acids at this position.(MHC) class I molecules is vital for initiation of the cellu-
A comparison of the B53 MHC structure with thoselar immune response (Townsend and Bodmer, 1989).
of the HLA-A2, HLA-A68, and HLA-B27 and the murineThe structural features of MHC class I peptide com-
H-2Kb and H-2Db alleles both clarifies and discriminatesplexes have been analyzed in a series of studies on
between the mechanisms by which MHC polymor-human and murine alleles (Bjorkman et al., 1987; Mad-
phisms determine peptide binding propensities. Mostden et al., 1993; Collins et al., 1994; Silver et al., 1992;
importantly, the additional data from the B53 peptideFremont et al., 1992, 1995; Zhang et al., 1992; Young et
complexes bring into sharp focus the mechanisms byal., 1994), which have established general principles for
which degeneracy of peptide binding is achieved. Se-peptide binding. The binding site in any one allele is
quence diversity in the central region of the peptide iscapable of binding a diverse series of peptides, and this
accommodated by a combination of flexibility of poly-capacity, coupled to thevariations in the peptide binding
morphic MHC residues at the bottom of the groove andspecificities of the different alleles, generates the broad
variation of bound water molecules underneath the pep-
tide. These data, in particular regarding the role of bound
water molecules, provide new insights that should aid§Current address: Howard Hughes Medical Instituteand Laboratory
in more accurate prediction of how a peptide epitopeof Molecular Medicine, Children's Hospital, Boston, Massachusetts
02115. binds to an MHC molecule.
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Figure 1. Omit |Fo| 2 |Fc|wcalc Electron Density Maps for which the Peptide Has Been Omitted from the Phasing Model.
2.3 AÊ resolution electron density contoured at about 1 s is displayed (program O; Jones et al., 1991) with the current models for the peptides.
The view is from above the MHC-binding groove with the peptide N terminus to C terminus mainchain direction running left to right. The
quality of the standard 2|Fo| 2 |Fc|wcalc electron density maps was excellent, allowing the conformation for both peptides to be modeled
unambiguously.
(A) The ls6 peptide (KPIVQYDNF).
(B) The HIV2 gag peptide (TPYDINQML).
Results refinement using X-ray diffraction data to 2.3 AÊ resolu-
tion. The crystal structure contains residues 1±276 of
the B53 heavy chain, residues 1±99 of b2m, and residuesOverall Structure of B53
The two specific MHC±peptide complexes were gener- 1±9 of the peptide in both complexes. There is little clear
electron density for the six residues of a Histidine tagated by a refolding protocol (Garboczi et al.,1992) involv-
ing addition of synthesized peptide to HLA-B53 heavy (incorporated at the C terminus of the expressed B53
heavy chain); none of these additional residues are in-chain (residues 1±276) and b2-microglobulin (b2m) pro-
duced separately in Escherichia coli expression sys- cluded in the model for the B53/ls6 structure and only
the first two residues of the tag (corresponding to resi-tems. The complexes crystallized in closely related unit
cells (Reid et al., 1996) and their structures were deter- due positions 277±278 of the heavy chain) are included
in the B53/HIV2 structure. For thesemodels, the Rvaluesmined by molecular replacement and crystallographic
Figure 2. The Structure of the HLA-B53 Peptide Complexes
(A) A schematic diagram of the B53 structure colored by crystallographic temperature factor to highlight regions of flexibility. Color, ranging
from blue (15 AÊ 2 or less) to red (50 AÊ 2 or greater) is based on the mainchain temperature factors of the ls6 complex. Temperature factors for
the model mainchain atoms exceed 60 AÊ 2 for the last two residues of the heavy chain and residues 74±75 of b2m in both complexes. Residues
221±226 of the B53/ls6 complex also have temperature factors exceeding 60 AÊ 2 (in the B53/HIV2 complex, this region is stabilized by a lattice
contact); this is consistant with the apparent inherent flexibility of this region noted for other crystal structures (Young et al., 1994; Madden
et al., 1992; Fremont et al., 1992). Since these residues are implicated in MHC class I binding to CD8 (Salter et al., 1990; Connolly et al., 1990;
Potter et al., 1989), the observations from the B53/ls6 structure lend further support to the suggestion that this local flexibility may represent
a functional feature. No crystal contacts involve the peptide in either complex; the area above the MHC peptide-binding groove is fully exposed
to solvent within the crystals.
(B) Comparison of the ls6 (red) and HIV2 (blue) bound peptide structures. The superposition is based on the a1a2 domains of the two
complexes. The stereodiagram illustrates the peptides as viewed through the a2 helix (an orthogonal view to that of Figure 1). The greatest
difference occurs at P7, in the ls6 peptide P7 (Asp) is oriented away from the binding groove and towards the a2 helix, while in the HIV2 gag
peptide P7 (Gln) binds underneath the peptide contacting MHC residue Tyr74 and introducing a nonstandard kink in the peptide main chain.
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(with a bulk solvent correction; Brunger, 1992) are 16.8% nature of the P2 side chain that can be accommodated
in this interface. Volume calculations (see Figure 4) re-and 20.5% on all data from 14±2.3 AÊ with stereochemis-
try typified by root mean square deviations from ideal veal no spare capacity for any additional atoms in this
interface. In B53, the reduced volume of the B pocketbond lengths of 0.013 AÊ and 0.014 AÊ . Electron density
for the two peptides is displayed in Figure 1. severely limits the possible P2 residues by size and it
is clear from Figure 4 that Pro provides an optimal fit. InThe overall structure of HLA-B53 is presented in
Figure 2A. The quaternary structure shows closest the structures of peptide complexes available for other
human alleles, there is a conserved hydrogen bond be-agreement with that of HLA-B27 (root±mean±square
[rms] deviation of 0.6 AÊ for superposition of all Ca tween the side chain of the polymorphic MHC residue
63 and the P2 mainchain amide. In the B53 complexes,atoms). Superposition of individual domains also reveals
greatest structural equivalence between the two HLA-B the presence of Pro at P2 precludes the formation of
this hydrogen bond and the hydrogen bonding potentialalleles (rms deviations between equivalent B53 and B27
Ca atoms of 0.48 AÊ , 0.48 AÊ , 0.27 AÊ for the a1/a2, a3, of Asn63 is instead satisfied by a conserved water mole-
cule. Further analysis of the reasons underlying theand b2m domains, respectively). Figure 2B shows the
conformation of the two peptides ls6 (KPIVQYDNF) and strong preference for Pro at P2 in the B53 peptide-
binding motif (Hill et al., 1992) will be considered in theHIV2 gag (TPYDINQML) when bound to B53. Major dif-
ferences between the two peptide conformations occur discussion section.
The D Pocketin the central region between positions P4 and P7. Thus,
the peptide positions at which residues are available for The binding of peptide residue P3 in a well-defined D
pocket is common to both B53 complexes (Figures 5Brecognition by the TCR differ between the two com-
plexes; in ls6, P1, P4, P6, P7, and P8 each contribute and 5C). In contrast with the B pocket, this pocket is
open to the region of plasticity in the binding surfacemore than 25 AÊ 2 to the solvent accessible surface, while
in HIV2 gag, only P4, P6, and P8 are similarly exposed. underneath the central portion of the peptide. This
allows for peptide sidechain variability; thus, the P3 po-
sition reveals no clear anchor residue type preferences
B53 Peptide-Binding Surface in the B53 peptide-binding motif (Hill et al., 1992). Com-
The B53 peptide-binding groove both allows peptide parison of the two peptide complexes does, however,
sidechain variability and imposes anchor residue prefer- point to an interplay between peptide residues P3 and
ences (Figure 3). Three clearly defined pockets in the P5, which may modulate the combinations of these resi-
protein surface (B, D, and F) contribute to these proper- dues compatable with binding to B53. In both com-
ties towards the two ends of the groove. In contrast, plexes, the side chain of P5 contacts a relatively mallea-
the detailed characteristics of the central region of the ble region of the binding surface (Figures 5B and 5C) in
peptide-binding surface vary in response to the particu- a broadly similar location to the area designated pocket
lar peptide, and in the ls6 complex are, to a large part, E in the HLA-A2 binding cleft (Saper et al., 1991). The
determined by bound water molecules. Data on the ex- binding of P3 and P5 are interlinked through mutually
tent to which an optimal fit between peptide and binding compensatory effects in the central portion of the B53-
surface is achieved, and the contribution of bound water binding groove primarily mediated by the side chain of
to the structural match, are presented in Figure 4. The polymorphic MHC residue Arg97. In the ls6 peptide, P3
description of the peptide-binding surface in B53 thus is an apolar residue (Ile), and Arg97 hydrogen bonds to
breaks naturally into four sections: the three distinct the polar peptide residue at P5 (Gln). Conversely, in the
conserved pockets and the central region of structural HIV2 peptide P5 is an isoleucine and Arg97 adopts an
plasticity. alternative conformation hydrogen bonding to the polar
The B Pocket Tyr residueat P3. Thus, the atoms, including water mole-
Figure 5A shows the B53 B pocket in which the Pro P2 cules, forming the apex of the D pocket may vary be-
anchor residue binds in both complexes. Phenylalanine tween complexes, while the MHC residues (Tyr99 and
at position 67 sterically precludes the fit of a longer P2 Tyr159) lining the entrance remain fixed, forming a hy-
side chain in B53 and gives rise to a relatively shallow drophobic channel filled by the apolar stalk of the P3
hydrophobic depression lined by polymorphic MHC res- side chain. The adaptability of the surface is therefore
idues Tyr7, Tyr9, Asn63, Ile66, Phe67, and Tyr99. The limited and only in the HIV2peptide complex is the entire
P2 Pro packs against residue Tyr7 at the base of the volume of this semiplastic pocket filled (see Figure 4).
pocket and Phe67 at the apex of the pocket. This is in Thus, for the two B53 peptide complexes the D pocket
contrast with the deeper B pocket previously observed differs from the B pocket in both accommodating
in the crystal structures of human class I alleles HLA- peptide variation and tolerating some imperfection in
A2, HLA-A68, and HLA-B27 (Madden et al., 1992, 1993; steric fit.
Silver et al., 1992; Guo et al, 1992), which have a smaller The Center of the Peptide Binding Region:
Val or Cys as residue 67. The shape complementarity A Crucial Role for Water
between the peptide P1±P3 main chain, the P2 side The major differences in conformation between the ls6
chain, and the B53 protein surface is very precise. Two and HIV2 peptides bound to B53 occur in the central
tightly bound water molecules that are invariant in posi- region of the peptide, from residues P4±P7, and this
tion for the two B53 complexes contribute to this inter- variation is mirrored by the peptide-binding surface (Fig-
face, and are involved in hydrogen-bonding networks ures 5B and 5C). In contrast with the rigidity of the
that lock the peptide mainchain conformation in place. surface underlying peptide residues P1±P3, the nature
of the peptide-binding surface beneath P4±P8 is ratherThis structural rigidity imposes strict constraints on the
Crystal Structures of MHC Class I HLA-B531
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Figure 3. The B53 Peptide-Binding Groove
(A) The surface of the MHC-binding groove in the ls6 complex is colored according to electrostatic potential (calculated in the absence of
the peptide or bound water molecules); blue denotes positive potential and red indicates negative potential. Electrostatic analysis and surface
display used program GRASP (Nicholls et al., 1991); the view of the peptide is similar to that of Figure 1.
(B) The electrostatic potential surface of B53 in the HIV2 complex.
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Figure 4. Surface Match Between B53 and
Bound Peptide
Cavities detected by a 1.4 AÊ radius probe are
represented in blue for calculations made in
the absence of bound water molecules and
in pink for the equivalent analyses including
water molecules (calculations used program
VOLUMES, R. Esnouf, unpublished data; dis-
played in program FRODO; Jones, 1985). The
MHC main chain is indicated by a blue ribbon,
the peptide atoms are highlighted by small
spheres, and the positions of water mole-
cules are marked by red crosses. Several
small cavities are present between side
chains at the protein surface and above the
peptide surface (the latter primarily a function
of the treatment of bulk solvent in the analy-
sis). The view is through the a2 helix of a
limited slab centered on the peptide main
chain.
(A) The ls6 complex. The important role of
bound water molecules at the MHC±peptide
interface is illustrated by cavity W, which van-
ishes on inclusion of the water structure. A
further substantial cavity at this interface, un-
occupied by either protein or water, lies be-
yond the displayed slab in front of the P3 Ile
sidechain.
(B) The HIV2 complex. Two cavities lie at the
MHC±peptide interface, both unoccupied by
either protein or water; cavity P6 represents
volume occupied by the P6 side chain in the
ls6 complex, and cavity F represents a hy-
drophobic region of the F pocket available to
aromatic C-terminal peptide side chains. No
other cavities are present at the MHC±
peptide interface.
malleable, allowing adaptation to accord with the partic- the binding groove. Since the typical arched conforma-
tion of the peptide main chain is maintained, this leavesular peptide bound. The B53 MHC residues in this region
provide a relatively polar surface, which is overlaid, to a substantial space underneath the peptide, which is
filled by seven water molecules. These tightly bounddiffering extents in the two complexes, by tightly bound
water molecules. The positions and nature of the atoms water molecules hold the peptide main chain in place by
a complex network of hydrogen bonds to polymorphiccontacting the peptide vary between the two complexes
but for each crystal structure are precisely defined, with MHC residues on the floor of the groove (Figure 5B).
The ls6 peptide conformation is further stabilized by thelow B factors indicating little thermal or static disorder.
Therefore, although this interface is capable of some P6residue (Tyr) resting in a shallow pocket at the surface
of the a1 helix. In the HIV2 peptide, P7 (Gln) pointsdeformation to accommodate different peptides, for any
one specific peptide the mold is rigidly set to achieve underneath the peptide and contacts MHC residue
Tyr74 (Figure 5C). In this case, the combined effect oftight binding. Volume calculations reveal that in both
complexes the surfaces produced by the B53 plus the burial of the P7 side chain deep within the binding
surface, and the conformational switch of MHC residuebound water molecules are well matched to the inter-
acting peptide (see Figure 4). Arg97 is the displacement of water molecules from un-
derneath the peptide. Additional space is also createdTwo interconnected mechanisms mediate the plastic-
ity of this area of the binding surface in B53. First, varia- by the shallow surface pocket, occupied in ls6 by P6,
now remaining vacant (see Figure 4).tion in the sidechain conformation of the polymorphic
MHC residue Arg97 and, second, variation in the struc- A comparison of the data from B53 with previous
observations for HLA-A2 (Madden et al., 1993) and H-2Kbture of the bound water. This region impinges on the D
pocket, and the accommodation of peptide sidechain (Fremont et al., 1992) illustrates the apparent universality
of conformational flexibility at a few MHC side chainsvariation at P3 and P5 through a switch in the sidechain
conformation of Arg 97 is detailed in the previous sec- as a mechanism for the accommodation of peptide side-
chain variability. Madden and coworkers (1993) also ob-tion. In contrast, radically different peptide residue con-
formations are allowed at P7, primarily by displacement served movement of Arg97 in HLA-A2 on comparison
of crystal structures for four nonameric peptide andof water molecules bound underneath the peptide. In
the ls6 peptide, residue P7 is an Asp and points out of one decameric peptide complexes. In contrast with the
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conformational switch observed in B53, which is deter- bound to HLA-B53 extends beyond the C terminus of
the HIV2 nonamer peptide because of the positioningmined by the nature of peptide residues P3 and P5,
HLA-A2 Arg97 is influenced by steric interactions with of the aromatic P9 side chain.
the side chains of P7 and P9 and is coupled to a move-
ment of Tyr116. In B53, MHC residue 116 is a Ser, a Peptide-Dependent HLA-B53 Mainchain
substantially smaller amino acid, which does not move Structural Variation
in concert with Arg97. The reduction in the size of the Superposition of the a1 and a2 domains of the two
polymorphic residue at 116 creates the space under- B53 single peptide structures (Figure 6A) reveals small
neath the peptide, which is filled by six water molecules concerted differences in the mainchain position for resi-
in the B53/ls6 structure and allows peptide residue Gln7 dues 56±62 of the a1 helix and residues 141±155 of the
in the B53/HIV2 structure to bind underneath the pep-
a2 helix (average deviations on Ca positions of 0.57 AÊ
tide. Thus, the role of conformational variation by Tyr116 and 0.38 AÊ , respectively, with maximum shifts of over
in A2 is replaced in B53 by variation in bound water 0.6 AÊ ). Such shifts are close to the estimated limit in
structure. Detailed comparison of the HLA-A2 and HLA- accuracy of the coordinates (the average deviation on
B53 complexes also reveals the influence of neighboring Ca positions between the two b2m structures is 0.22 AÊ
polymorphic MHC residues, situated in the base of the and this is typical of the baseline agreement between
binding groove, on the conformational space available the two complexes). Since the two crystal structures
to Arg97. In HLA-A2 Arg97 is positioned directly under- have lattice contacts in this area and differences in unit
neath the peptide in both orientations, equidistant be- cell dimensions, in isolation this result, in particular for
tween His114 and His74 and the conformational switch the a2 helix, is of marginal significance as evidence of
employs rotation about the Ca±Cb bond. In HLA-B53, peptide-induced variation. However, similar differences,
Arg97 hydrogen bonds to Asp114 in both orientations localized in the same regions of the a1 and a2 helices,
and is therefore located towards the a1 helix and rotates have been observed between different single peptide
about the Cb±Cg bond. crystal structures for both the mouse H-2Kb (Fremont
The F Pocket et al., 1992) and the human HLA-A2 (Madden et al., 1993)
The B53 peptide-binding motif shows an unusually class Istructures. The recurrance of similar observations
broad range of C-terminal residues, spanning both ali- in three different systems argues for an enhanced de-
phatic and aromatic amino acids (Hill et al., 1992). This gree of mainchain plasticity in these two regions. It is
preference is largely attributable to the small Ser side possible that the observed difference in the a2 helix of
chain at position 116 in B53, which opens up the F the B53 structures is due to the extension of the ls6
pocket to the water-mediated plasticity of the central peptide C terminus relative to that of the HIV2 peptide;
peptide binding region and enables a bulky aromatic hydrogen bonding to the peptide main chain is con-
side chain to fit (Figure 5D). This is in contrast with served and appears to shift the a2 helix slightly in this
the Tyr at position 116 in HLA-A2, which, despite some region. More generally, the positions of the P5 and P7
conformational flexibility, sterically hinders the accom- residues of the peptide exert direct influences on the
modation of large aromatic residues and confers the kinked portion of the a2 helix (centred on residues 150±
preferance for Leu as a C-terminal (PC) anchor residue. 152). Similarly, the small changes in the a1 helix could
In addition to Ser 116, the small alanine side chain at be due to the difference in binding of P6 between the two
position 81 also effectively increases the volume of the complexes or the interactions of the solvent-exposed P4
F pocket. The C termini of the peptides are bound in side chain, or both.
the F pocket by conserved hydrogen bonds (Madden
et al., 1992). The consequent surface rigidity is compara-
Effects of Polymorphism on MHCble to that at the interface with the N-terminal residues
Framework StructureP1±P3, but as the F pocket opens into the central region
Superpositions of HLA-B53 a1 and a2 domains with theof surface plasticity is thus more closely related in nature
corresponding domains in the human class I structuresto the D pocket than the strictly constrained B pocket.
HLA-A2, HLA-A68, and HLA-B27 reveal significant dif-The C-terminal (P9) side chains, Leu and Phe for the
ferences in the mainchain positions of a1 helix residuesHIV2 and ls6 peptides, respectively, are orientated
66±75 (Figure 6B). This is in agreement with previouslydownwards to the floor of the binding groove and pack
noted variations in this region between HLA-A2, HLA-within the F pocket against MHC side chains Tyr123 and
A68, and HLA-B27 (Guo et al., 1993). The largest differ-Asn77. The Phe side chain of the ls6 peptide shows a
ence is observed between the HLA-A2 and HLA-B53particularly favorable interaction, ring stacking against
structures, where the average deviation in this regionTyr123 (Figure 5D), while the Leu of the HIV2 peptide
(1.1 AÊ on Ca atoms) is significantly above coordinatedoes not entirely fill the available volume (see Figure 4).
error. The shift in the a1 helix position between B53 andThe aromatic interaction orientates the ls6 peptide C
the other human alleles appears to be influenced byterminus so that it extends 0.5 AÊ beyond that of the HIV2
the nature of the polymorphic residues that lie at thepeptide. This slightly altered position for the C terminus
interface of this helix and the floor of the peptide-bindingof the ls6 peptide in the binding groove superimposes
groove, namely at positions 63, 67, and 74. In HLA-A2,with that of the Hep B decamer peptide bound to HLA-
HLA-A68, and HLA-B27 there is hydrogen bonding fromA2 (Madden et al., 1993). The Hep B peptide C terminus
MHC position 63 to the P2 mainchain nitrogen. For A68,extends beyond those of the four nonameric peptides
where residue 63 is Asn, which is shorter than the Glu63bound to HLA-A2 as a result of the extra residue in the
centre of the peptide, whereas the ls6 nonamer peptide in HLA-A2 and HLA-B27, conservation of this hydrogen
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bond may contribute to the relative shift in the a1 helix (compared with Val67 and Asp74 in A68). Indeed, when
combined with the steric constraints already imposedtowards its C terminus and hence cause the B pocket
to be slightly smaller than in HLA-A2. In B53, for which by Phe67, such a shift would be expected virtually to
abolish the B pocket. Instead, in the B53 complexesposition 63 is also Asn, a similar shift to allow hydrogen
bonding to the P2 mainchain nitrogen may be precluded Asn63 hydrogen bonds to a conserved water, main-
taining a shallow but distinct B pocket, and, probablyby the influence of the bulky Phe67 and Tyr74 residues
Crystal Structures of MHC Class I HLA-B531
223
Figure 5. The Peptide-Binding Surface of B53
Peptide residues are colored red. The B53 main chain is represented schematically in blue and key side chains are shown in white; dashed
lines indicate hydrogen bonds and, in (B) and (C), green spheres mark the positions of tightly bound water molecules.
(A) Stereodiagram of the B pocket. The view is through the a1 helix.
(B) The central region in the ls6 complex. The view for this and the following panels is through the a2 helix.
(C) The central region in the HIV2 complex.
(D) The F pocket, showing favorable ring stacking between the ls6 C-terminal (P9) peptide residue Phe and MHC residue Tyr123.
Immunity
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Figure 6. Structural Variations of the MHC Framework in the a1a2 Domain
The view is from the standard orientation above the MHC-binding groove (a1 helix at the top of the picture).
(A) A ribbon diagram colored by structural variation between the ls6 and HIV2 peptide complexes. Regions colored green show the least
variation in Ca position (0.2 AÊ or less, reflecting the general level of coordinate error), while those in red correspond to changes of 0.6 AÊ or
greater. Values are taken from a superposition based on all Ca atoms in the B53 a1a2 domain.
(B) Ca traces showing the difference in width of the HLA-A2 (red) and HLA-B53 (blue) peptide-binding grooves. The superposition is based
on all equivalent Ca atoms in the a1a2 domain.
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combined with the influence of residues 67 and 74, 116 (Elliott et al., 1993). For B53, in addition to freeing
extra volume within the F pocket, the relatively smallallows a shift of the a1 helix away from the a2 helix by
more than 1.0 AÊ when compared with HLA-A2. The loss Ser116 allows communication between the pocket and
the structurally plastic space beneath the center of theof a hydrogen bond to the P2 mainchain nitrogen is
abrogated by the use of Pro at this position in B53- peptide, further increasing the potential adaptability of
this region.restricted peptides. The possible association of the a1
helix with long-range effects of polymorphic residues
on peptide binding specificity has been discussed pre- The Accommodation of Peptide
Sidechain Variabilityviously (Guo et al., 1993) and the current observations
are in accord with this theme. In particular, the B53 Fremont et al. (1995) discuss the potential of water mole-
cules to fill empty cavities and make hydrogen bondscomplexes suggest that the polymorphic residues that
line the side of the a1 helix may control the width, as to stabilize peptide binding to MHC class I molecules.
The current comparison of two B53 peptide complexeswell as the detailed local nature, of the peptide-binding
groove. provides a particularly clear example of the use of tightly
bound water molecules as an additional key mechanism
for accommodating peptide variability. Radically differ-
Discussion ent peptide conformations at P7 are compensated for
by the presence or absence of a cluster of bound water
Primary Anchor Residue Specificity molecules beneath the peptide. This appears to repre-
The structures of the two B53 single peptide complexes sent an enhanced degree of adaptability in the peptide-
provide insight into several features that contribute to binding surface of B53 compared with that of HLA-A2,
the repertoire of peptide binding specificity provided by a feature that may be facilitated by the general widening
human MHC class I alleles. The B53 peptide-binding and, in places, deepening of the peptide-binding groove
motif shows a strong preference for Pro at P2 but dis- in B53 versus A2. Thus, in B53 a conformationally stable
criminates rather less at the PC anchor position, reveal- Ser116 plus a network of polar atoms (i.e., the bound
ing a broad preference for apolar residues with some water), capable of variation in both position and number,
specificity for the aromatic residues Trp and Phe (Hill replaces the more limited conformational variation of
et al., 1992). P2 is an anchor residue in the peptide- the Tyr116 side chain seen in HLA-A2. As in HLA-A2,
binding motifs of most human MHC class I alleles so variation in this system is coupled to variation at Arg97.
far analyzed (Rammensee and Friede, 1995), an excep- It appears likely that dramatic alterations in bound water
tion is HLA-B8 (Sutton et al., 1993), and three mainspeci- structure provide a major component of the functional
ficities have been revealed: aliphatic residues, Arg, and plasticity in the peptide-binding surface of a number of
Pro. The binding of the P2 anchor residue side chain in MHC class I alleles.
the B pocket is common to all HLA complex structures Clearly, water molecules can provide a powerful agent
determined to date and details of the architecture of for fine tuning the fit between MHC molecule and pep-
aliphatic- (HLA-A2 and HLA-A68) and Arg- (HLA-B27) tide; however, the B53 complexes also demonstrate that
specific B pockets are established (Madden et al., 1992, the degrees of freedom of such a system are still rela-
1993; Silver et al., 1992); B53 now provides an example tively limited. Hydrogen bonding requirements energeti-
of a Pro-specific B pocket. It has been suggested that cally constrain certain positions to be occupied by polar
a Phe or Tyr at MHC residue67 would block the B pocket atoms in the formation of a stable complex. An element
(Elliott et al., 1993; Barber et al., 1995) and, in B53, the of adaptability is introduced by the possible variation in
effect of Phe67 is indeed to close off space available in the identity of these atoms; thus, there is a potential
HLA-A2, HLA-A68, and HLA-B27 such that the comple- interchangeability of water and MHC or peptide atoms
mentarity in shape and charge between the Pro side at certain positions in the binding groove that can com-
chain and this now shallow hydrophobic pocket is opti- pensate for peptide binding variations. Indeed, water
mal. Pro is distinctive in lacking the hydrogen-bonding molecules can also modulate the effects of allelic varia-
potential of a free mainchain nitrogen. In other HLA tion; for example, the position of the atom donating a
structures, the P2 mainchain nitrogen bonds to the side hydrogen bond to the P3 mainchain carbonyl is con-
chain of MHC residue 63, but in B53, the broadened served between alleles, but in HLA-A2 it is an imidazole
binding groove combined with the relatively short nature nitrogen of His70, while in B53 it is the oxygen of a water
of Asn63 precludes this interaction and may also con- molecule bound to the shorter Asn70.
tribute to the specificity for Pro. The PC anchor residue An understanding of the constraints on the positioning
binds in the F pocket and again human alleles display of atoms in the binding groove will be crucial for the
three main specificities; aliphatic (representative struc- improvement of predictive protocols. From the current
tures HLA-A2 [Madden et al., 1993; Collins et al., 1994] study, it appears that water molecules in the groove can
and the mouse alleles H-2Kb and H-2Db; [Fremont et al., usefully be grouped into three general categories: fixed,
1992, 1995; Zhang et al., 1992; Young et al., 1994]), semifixed, and variable. The firstcategory of water mole-
positively charged (HLA-A68 and HLA-B27; Silver et al., cules (fixed) are invariant between alleles; for example,
1992; Madden et al., 1992), and aromatic. Comparison the water molecule in the A pocket, which facilitates the
of the B53/ls6 and B53/HIV2 complexes demonstrates conserved hydrogen bonding network to the peptide N
that a PC Phe but not Leu provides an optimal steric terminus and is conserved in all MHC class I molecules
match to the B53 F pocket. The use of aromatic residues so far studied. These fixed water molecules satisfy hy-
as the PC anchor correlates with Ser at MHC residue drogen bonding requirements that are conserved be-
tween alleles and maintain the overall structure of the
Immunity
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Table 1. Statistics for Crystallographic Structure Determination
ls6 HIV2 gag
KPIVQYDNF TPYDINQML
Unit cell dimensions (AÊ ) a 5 51.3 b 5 83.3 c 5 112.4 a 5 50.9 b 5 82.5 c 5 109.7
Data collection temperature Ambiant 100 K
Resolution range 15±2.3 AÊ 15±2.3 AÊ
Rmerge (on I) 9.0% 8.8%
Redundancy 3.8 3.7
Completeness 97.1% 97.9%
Rcryst 16.8% 20.5%
Stereochem. deviations
rms D(bond) 0.013AÊ 0.014AÊ
D(angles) 1.78 1.88
D(dihedrals) 26.88 26.78
B Factors deviations
rms DB(bond) 3.5AÊ 2 3.6AÊ 2
DB(angles) 5.4AÊ 2 5.4AÊ 2
Ramachandran plot
Favored regions 91% 89%
Disallowed regions None None
Values are given for the resolution of the data, Rmerge (S | I 2 kIl | / S kIl), the redundancy of the data measurements (observations/unique
reflection), the fraction of the theoretically possible data measured, the crystallographic R factor, rms deviations from ideal values for bond
lengths, angles, and dihedral angles (Engh and Huber, 1991), rms deviations in B factors between bond and bond±angle related atoms, and
percentage of residues within the most favored regions of the Ramachandran plot (Laskowski et al., 1993). The current crystal structures for
the ls6 and HIV2 complexes comprise 3168 and 3184 nonhydrogen protein atoms with 113 and 187 ordered water molecules, respectively.
The lower value of the crystallographic R factor for the ls6 complex simply reflects the superior quality of the X-ray diffraction data.
A dilution method of refolding (Garboczi et al., 1992) was used topeptide±MHC complex. The second category of water
generate two specific HLA-B53 peptide complexes from denaturedmolecules (semifixed) are interchangeable in position
HLA-B53 heavy chain and b2m (produced using the vector pHN1b2m,with MHC or peptide sidechain atoms and act to satisfy a gift from D. Garboczi) and synthesized peptide. After refolding,
positions of conserved hydrogen bonding requirement the solution was concentrated and purified by gel filtration on a
between alleles, while maximizing the flexibility of the FPLC system (Pharmacia) in 20 mM Tris±HCl (pH 7.5), 150 mM NaCl.
The B53/ls6 complex crystallized at 218C as thick plates (0.3system. The third category of water molecules (variable)
mm 3 0.2 mm 3 0.1 mm) from drops containing a 1:1 ratio of proteinfill the space between the peptide and the floor of the
(at 10 mg/ml) and reservoir solution, suspended above a reservoirbinding groove and act to satisfy hydrogen bonding
of 0.2 M calcium acetate, 0.1 M sodium cacodylate (pH 6.5), 18%requirements, which vary due to sidechain polymor-
PEG8000. These crystals were used to promote crystal growth of the
phism and peptide sidechain variability. Water mole- B53/HIV2 complex by streak seeding in similar conditions (unpub-
cules that are semifixed or variable in position, in con- lished data). For cryocrystallography, crystals were transfered to
reservoir solution containing an additional 25% glycerol.trast with fixed waters, contribute to the plasticity of the
peptide-binding surface. These, together with flexible
Data Collection and Processingpolymorphic residues, provide some functional mal-
Data relating to the crystallographic analysis is presented in Tableleablility, which allows modulation of the specificity to
1. Both complexes crystallized in space group P212121 in closely
permit the binding of a range of peptides of diverse related unit cells. Data collection was carried out (on room tempera-
sequence. ture and cryo-cooled crystals for the ls6 and HIV2 peptide com-
plexes, respectively) at station 9.6 of the Synchrotron Radiation
Source, Daresbury United Kingdom (l 5 0.87 AÊ , collimation 0.16 3Experimental Procedures
0.16 mm2) utilizing a MAR-research imaging plate system (30 cm
diameter). We required four crystals for collection of a full data setProtein Production and Crystallization
A full-length B53 cDNA clone was prepared from the cell line Hmy- at room temperature, as compared with a single cryo-cooled crystal.
The diffraction data were autoindexed, integrated, and correctedB53 (a gift from M. Takiguchi; Yamamoto et al., 1990). The B53
expression vector was constructed by polymerase chain reaction for Lorentz and polarization effects with the program DENZO (Otwi-
nowski, 1993), followed by scaling and merging in SCALEPACK(PCR) of the gene fragment containing the coding region for residues
1±276, using the primers 59-GCGCGGATCCCACTCCATGAGGTAT (Otwinowski, 1993).
TTC-39 and 59-CCGCAAGCTTTTATCAATGGTGGTGATGATGGTG
TGGCTCCCATCTCAGGGT-39. The 39 primer contains the coding Molecular Replacement and Refinement.
A molecular replacement solution for the ls6 complex was initiallysequence for a C-terminal HIS6 tag. The resulting fragment was cut
with the restriction enzymes BamHI and HindIII and cloned into the obtained using the HLA-B27 crystal structure (excluding peptide;
Madden et al., 1992) in program AMoRe (Navaza, 1994). Rigid bodyexpression vector pGMT7 (a pET derivative; Studier et al., 1990).
The expression plasmid was transformed into the E. coli strain refinement of this solution in program XPLOR (Brunger, 1992)
yielded an R factor of 38% on data from 10.0±4.0 AÊ resolution andBL21(DE3)pLysS (Novagen) and grown at 378C in Luria±Bertani me-
dium containing 20 mg/ml carbenicillin (Sigma). Protein expression a difference Fourier map calculated on the basis of these phases
showed clear electron density for the peptide (electron density mapwas induced at midlog phase (A600 5 0.6) with 0.5 mM isopropyl
b-D-thiogalactopyranoside (IPTG) (NovaBiochem). After 4 hr, the calculations were performed with the CCP4 programs; CCP4, 1994).
The HLA-B27 structure was further refined in XPLOR against thecells were harvested and lysed with lysozyme (Sigma). Inclusion
bodies were isolated and solubilized in 8 M urea as described by B53 diffraction data (conjugate gradient minimization: 250 cycles
on 10.0±3.0 AÊ resolution data, 250 cycles on 10.0±2.3 AÊ resolutionGarboczi et al. (1992).
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data, followed by restrained temperature factor refinement and a in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 5,
179±190.standard slowcool protocol: 3000 K to 200 K using 10.0±2.3 AÊ resolu-
tion data; Bruger and Krukowski, 1990) to yield an R factor of 28.9%. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strom-
2.3AÊ resolution 2|Fo| 2 |Fc| and |Fo| 2 |Fc| maps, generated using inger, J.L., and Wiley, D.C. (1987). Structure of the human class I
phases calculated from this model, then facilitated manual rebuild- histocompatibility antigen, HLA-A2. Nature 329, 506±512.
ing of the MHC model with the correct B53 sequence and inclusion Bruger, A.T., and Krukowski, A. (1990). Slow-cooling procedures for
of the peptide. Electron density maps were displayed and model crystallographic refinement by simulated anealing. Acta Cryst. A46,
coordinates fitted on an Evans and Sutherland ESV workstation 585±593.
using the interactive computer graphics program FRODO (Jones,
Brunger, A. (1992). XPLOR version 3.1. A System for X-Ray Crystal-1985). A bulk solvent correction, as implemented in version 3.1 of
lography and NMR (New Haven, Connecticut: Yale University Press).XPLOR (Brunger, 1992), allowed all measured data from 15.0±2.3 AÊ
CCP4 (1994). The CCP4 suite: programs for protein crystallography.to be incorporated into the refinement. Several further rounds of
Acta Cryst. D50, 760±763.refinement using standard XPLOR protocols (Brunger, 1992), and
rebuilding to 2.3 AÊ resolution 2|Fo| 2 |Fc|wcalc maps, during which Collins, E.J., Garboczi, D.N., and Wiley, D.C. (1994). Three-dimen-
ordered water molecules were added, resulted in the current model sional structure of a peptide extending from one end of a class I
for the ls6 complex. The stereochemical and force field parameters MHC binding site. Nature 371, 626±629.
of Engh and Huber (1991) were used throughout. Connolly, J.M., Hansen, T.H., Ingold, A.L., and Potter, T.A. (1990).
A molecular replacement solution for the HIV2 complex was Recognition by CD8 on cytotoxic T lymphocytes is ablated by sev-
readily obtained in XPLOR using the refined ls6 complexcoordinates eral substitutions in the class I alpha 3 domain: CD8 and the T-cell
(with peptide excluded). This complex was then refined using similar receptor recognize the same class I molecule. Proc. Natl. Acad. Sci.
protocols to those employed for the ls6 complex. Crystallographic USA 87, 2137±2141.
statistics for both final models are presented in Table 1.
Corr, M., Boyd, L.F., Frankel, S.R., Kozlowski, S., Padlan, E.A., and
Margulies, D.H. (1992). Endogenous peptides of a soluble major
Analysis and Visualization histocompatibility complex class I molecule, H-2Lds: sequence mo-
The program PROCHECK (Laskowski et al., 1993) was utilized to tif, quantitative binding, and molecular modeling of the complex. J.
assess the quality of the final structure. Secondary structural assign- Exp. Med. 176, 1681±1692.
ments and solvent accessibilities were calculated in program DSSP
Elliott, T., Driscoll, P., Smith, M., and McMichael, A. (1993). Peptide(Kabsch and Sander, 1983). Structural superpositions were per-
epitope selection by class I MHC molecules. Curr. Biol. 3, 854±866.formed using the program SHP (Stuart et al., 1979). Figures 2, 5,
Engh, R.A., and Huber, R. (1991). Accurate bond and angle parame-and 6 were produced using a version of Molscript v1.4 (Kraulis,
ters for X-ray protein-structure refinement. Acta Cryst. A47, 392±400.1991) with modifications by R. Esnouf and rendered with Raster3D
(Merritt and Murphy, 1994). Figure 1 was produced using O v5.10 Fremont, D.H., Matsumura, M., Stura, E.A., Peterson, P.A., and Wil-
(Jones et al., 1991). These figures were displayed on a Silicon Graph- son, I.A. (1992). Crystal structures of two viral peptides in complex
ics work station using IRIS Showcase for annotation. Atomic coordi- with murine MHC class I H-2Kb. Science 257, 919±927.
nates for structural comparisons were obtained from the Protein Fremont, D.H., Stura, E.A., Matsumura, M., Peterson, P.A., and Wil-
Data Bank, Brookhaven National Laboratory. The analysis of protein son, I.A. (1995). Crystal structure of an H-2Kb±ovalbumin peptide
cavities of the MHC±peptide interface was made using the program complex reveals the interplay of primary and secondary anchor
VOLUMES (R. Esnouf, unpublished data). positions in the major histocompatibility complex binding groove.
Proc. Natl. Acad. Sci. USA 92, 2479±2483.
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